ClinVar Miner

Submissions for variant NM_000059.3(BRCA2):c.4915G>A (p.Val1639Ile) (rs80358716)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000129029 SCV000172937 benign Hereditary cancer-predisposing syndrome 2014-11-19 criteria provided, single submitter clinical testing
Breast Cancer Information Core (BIC) (BRCA2) RCV000031513 SCV000146505 uncertain significance Breast-ovarian cancer, familial 2 2002-05-29 no assertion criteria provided clinical testing
Color RCV000129029 SCV000537492 likely benign Hereditary cancer-predisposing syndrome 2015-07-28 criteria provided, single submitter clinical testing
Counsyl RCV000031513 SCV000488073 uncertain significance Breast-ovarian cancer, familial 2 2015-12-30 criteria provided, single submitter clinical testing
GeneDx RCV000427785 SCV000512365 likely benign not specified 2017-08-29 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Integrated Genetics/Laboratory Corporation of America RCV000587911 SCV000694811 likely benign not provided 2017-02-15 criteria provided, single submitter clinical testing Variant summary: The BRCA2 c.4915G>A (p.Val1639Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. 3/4 in silico tools predict a benign outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was observed in the large and broad control population from ExAC with an allele frequency of 1/119,420 control chromosomes which does not exceed the predicted maximum expected allele frequency for a pathogenic BRCA2 variant of 1/1,333. The variant of interest has been reported in affected individuals via publications, although with limited information (ie lack of co-occurrence and co-segregation data). However, a reputable database cites the variant to co-occur with potentially pathogenic BRCA1 variants, c.2457delC (p.Asp821fsX25 pathogenic in GE) and exon13ins6kb, along with an internal LCA sample reporting the variant to co-occur with another pathogenic BRCA2 variant, c.5073dupA (p.Trp1692fsX3 pathogenic in GE). In addition, multiple reputable clinical laboratories cite the variant with a classification of "benign." Considering all available information, the variant of interest is classified as Likely Benign.
Invitae RCV000044519 SCV000072532 likely benign Hereditary breast and ovarian cancer syndrome 2017-12-19 criteria provided, single submitter clinical testing
Laboratory of Molecular Diagnosis of Cancer,West China Hospital, Sichuan University RCV000240704 SCV000265941 uncertain significance Neoplasm of the breast 2015-11-01 criteria provided, single submitter research
Sharing Clinical Reports Project (SCRP) RCV000031513 SCV000054118 benign Breast-ovarian cancer, familial 2 2009-11-11 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.